HUGH STARKS: Open Payments
NPI 1548206527 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 61 payments from 13 companies in 2025. Trend: 2023 $472 · 2024 $666 · 2025 $1,647
Food & beverage: $1,640Education: $8
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $315 |
| Supernus Pharmaceuticals, Inc. | 23 | $273 |
| Neurocrine BioSciences, Inc. | 4 | $216 |
| ABBVIE INC. | 5 | $182 |
| E.R. Squibb & Sons, L.L.C. | 5 | $180 |
| Axsome Therapeutics, Inc. | 2 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Tris Pharma Inc | 4 | $82 |
| Lundbeck LLC | 3 | $55 |
| Corium, LLC | 3 | $33 |
Products named: Qelbree, UZEDY, INGREZZA, VRAYLAR, COBENFY, Auvelity, AUSTEDO XR, CAPLYTA.
Industry payments across IN — which companies pay providers there.
